Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAQ | Class A Ordinary Shares | Conversion of derivative security | +1.87M | +474.81% | 2.26M | Jul 24, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAQ | Class B Ordinary Shares | Conversion of derivative security | $0 | -1.87M | -69.18% | $0.00 | 832K | Jul 24, 2024 | Class A Ordinary Shares | 1.87M | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The Class B Ordinary Shares are convertible, at the option of the holder, into Class A Ordinary Shares on a one-for-one basis, for no additional consideration, and have no expiration date. On July 24, 2024, the Reporting Persons elected to convert 1,867,604 Class B Ordinary Shares held by them into 1,867,604 Class A Ordinary Shares. |
F2 | HCG Opportunity, LLC ("HCG Opportunity") is the record holder of the securities reported herein. HCG Opportunity MM, LLC ("HCG Opportunity MM") is the sole member of HCG Opportunity. Thomas D. Hennessy and Daniel J. Hennessy are the co-managing members of HCG Opportunity MM, serve on the Issuer's board of directors and report their beneficial ownership of the securities held directly by HCG Opportunity on separate Section 16 reports. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. |